{'fraction_non_alphanumeric': 0.03900709219858156, 'fraction_numerical': 0.016843971631205674, 'mean_word_length': 5.272222222222222, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Actualización en materia de cirugía ortopédica y traumatología de la repercusión clínica de la utilización de PRGF: plasm rich in growth factors

Objective: Update on plasma rich in growth factors (PRGF) in the field of orthopedic surgery and traumatology. Method: Review of 136 studies on PRGF relevant in the field of orthopedic surgery and traumatology published in the last 10 years. Results: The largest number of studies on PRGF has been performed in the field of osteoarthritis of the knee (25%), followed closely by the comparative studies between PRGF and hyaluronic acid (19%). The studies on ligamentous and tendinous pathology (14%), the joint pathology different from the knee (10%).The remaining studies addressed pseudoarthrosis, osteonecrosis and nerve regeneration among others. The most commonly used platelet products were Plasma Rich in Platelets (73%), Plasma Rich in Growth Factors (15%) and Plasma Rich in Fibrin (12%). Conclusions: To document the preparation of platelet prod-ucts, establish the precise concentration of growth factors and carry out long-term follow-up is es-sential for future studies.